Semba J, Wakuta M S
Division of Health Sciences, University of the Air, Chiba, Japan.
Gen Pharmacol. 1998 Sep;31(3):399-404. doi: 10.1016/s0306-3623(98)00047-0.
The effects of the glutamate transporter inhibitor, trans-PDC, on extracellular amino acids, were investigated in the frontal cortex, striatum, hippocampus and cerebellum of rats using in vivo microdialysis. Trans-PDC infusion (0.1, 1, 10 mM) dose-dependently increased Glu and Asp levels, and these increases in the cerebellum were smaller than those in other brain regions. A small but significant dose-dependent increase was observed for Gly and Tau. However, high extracellular Glu induced by trans-PDC was not sufficient to increase extracellular DA in the striatum and frontal cortex.
使用体内微透析技术,研究了谷氨酸转运体抑制剂反式-2,4-二氨基丁酸(trans-PDC)对大鼠额叶皮质、纹状体、海马体和小脑中细胞外氨基酸的影响。输注反式-2,4-二氨基丁酸(0.1、1、10 mM)剂量依赖性地增加了谷氨酸(Glu)和天冬氨酸(Asp)水平,且这些增加在小脑中比在其他脑区小。甘氨酸(Gly)和牛磺酸(Tau)呈现出小但显著的剂量依赖性增加。然而,反式-2,4-二氨基丁酸诱导的高细胞外谷氨酸水平不足以增加纹状体和额叶皮质中的细胞外多巴胺(DA)。